Jim Simons Spero Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 832,165 shares of SPRO stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
832,165
Previous 970,907
14.29%
Holding current value
$1.96 Million
Previous $699,000
245.21%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding SPRO
# of Institutions
46Shares Held
13.6MCall Options Held
9.3KPut Options Held
100-
Vanguard Group Inc Valley Forge, PA1.95MShares$4.6 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.62MShares$3.81 Million0.86% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.19 Million14.54% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.1 Million0.17% of portfolio
-
Murchinson Ltd. Toronto, A6874KShares$2.06 Million0.08% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $82.8M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...